adherence with urate-lowering therapies for the treatment of gout与urate-lowering治疗痛风的治疗依从性.pdfVIP

Available online /content/11/2/R46 Vol 11 No 2 Open Access Research article Adherence with urate-lowering therapies for the treatment of gout Leslie R Harrold1,2,3, Susan E Andrade1,2,3, Becky A Briesacher1,2, Marsha A Raebel3,4, Hassan Fouayzi1, Robert A Yood1,5 and Ira S Ockene2 1Department of Medicine, the Meyers Primary Care Institute, 425 North Lake Avenue Worcester, MA 01605, USA 2Department of Medicine, University of Massachusetts Medical School, 377 Plantation Street Worcester, MA 01605, USA 3The HMO Research Network Center for Education and Research in Therapeutics, Department of Medicine, University of Massachusetts Medical School, 377 Plantation Street Worcester, MA 01605, USA 4Department of Research, Kaiser Permanente, Colorado Institute for Health Research, PO Box 378066 Denver, CO 80237-8066, USA 5Department of Medicine, Fallon Clinic, 425 North Lake Avenue Worcester, MA 01605, USA Corresponding author: Leslie R Harrold, Leslie.Harrold@ Received: 17 Nov 2008 Revisions requested: 7 Jan 2009 Revisions received: 5 Feb 2009 Accepted: 27 Mar 2009 Published: 27 Mar 2009 Arthritis Research Therapy 2009, 11:R46 (doi:10.1186/ar2659) This article is online at: /content/11/2/R46 © 2009 Harrold et al.; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Abstract Introduction Adherence to urate-lowering drugs (ULDs) has not were non-adherent (MPR 0.8). In adjusted analyses, been well evaluated among those with gout. Our aim was to pred